Journal
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
Volume 22, Issue 2, Pages 112-118Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MED.0000000000000138
Keywords
acyltransferase; arachidonic acid; lipid mediators; phospholipase A(2); phospholipids
Categories
Funding
- Canadian institutes of Health Research [160550]
- Atlantic Innovation Fund [201211]
- Canadian Breast Cancer Foundation Atlantic [R13F13]
- New Brunswick Innovation Research Chair in Biosciences
- Canadian Institutes of Health Research
- New Brunswick Health Research Foundation
Ask authors/readers for more resources
Purpose of review To highlight some of the recent advances related to the control of polyunsaturated fatty acid (PUFA) incorporation and remodeling in membrane glycerophospholipids in inflammatory cells. Recent findings Several enzymes have recently been identified that are associated with the control of PUFA incorporation and remodeling into membrane phospholipids and their release. The functional roles of the different enzyme isotypes in the control of PUFA availability for lipid mediator biosynthesis and cell signaling are only now being established. The expression of specific acyl-CoA synthetase, lysophospholipid acyltransferase and phospholipase A(2) isotypes has recently been shown to have an impact on membrane PUFA content, on the production of lipid mediators and on inflammation. Summary A better understanding of the complex processes associated with the control PUFA remodeling in membrane phospholipids may lead to the discovery of new therapeutic targets for the treatment of inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available